FindTrial
Sign In

Study to check the safety and efficacy of skin product on human

The objective of this study is to evaluate the in-vivo safety and efficacy of skin care formulations in terms of reduction in under eye dark circles, pigmentation and fine lines on healthy human participants - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113518
Enrollment
30
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Regime with Dark Circle Peel, SkinQ Moisture Balm and SkinQ Brightening Serum: This regimen consists of three products. Dark Circle Peel is applied around both eyes on alternate nights

Sponsors

SLJ Solution Logistics LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian Female participants 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having mild to moderate dark circles. 5.Having fine lines

Exclusion criteria

Exclusion criteria: 1.Being pregnant or breastfeeding or having 2.stopped breastfeeding within the past three months 3.Refusing to provide assent by not signing the informed consent form 4.Taking part in another study that may interfere with this study 5.Being insulin dependent diabetic or non insulin dependent diabetic with recent therapy within the past six months 6.Having progressive asthma either under treatment or with an asthma attack within the past two years 7.Having a chronic skin disease that may modify skin reactivity in the test area except in studies specifically conducted on that skin disease 8.Having unstable thyroid disease requiring treatment that has not been stable for at least six months 9.Being diagnosed with epilepsy 10.Receiving chronic medicinal treatment including aspirin based products anti inflammatory drugs antihistamines or corticosteroids administered by either general or local routes The only permitted medication is paracetamol 11.Having skin hypersensitivity 12.Having a diagnosed or highly probable allergy to one or more ingredients of the cosmetic products 13.Having undergone surgery requiring general anesthesia for more than one hour within the past six months

Design outcomes

Primary

MeasureTime frame
Reduction in under eye dark circles, pigmentation and fine linesTimepoint: Baseline, 14 days and 28 days—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in08657063276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026